ExecSalaries
Home · Compare

Mayukh Sukhatme vs Michael A. Marks

💰 How does your salary compare?
See how you rank against the world's top executives — free, instant, SEC-backed data
Try it →
Mayukh Sukhatme earned $250.1M (14014%) more than Michael A. Marks in their most recent fiscal years on record.
CompanyRoivant SciencesHCA Healthcare
TitlePresident and Chief Investment OfficerExecutive Officer
IndustryHealthcareHealthcare
Fiscal YearFY2024FY2025
Total Pay$251.9M$1.8M
Base Salary$550,000
Stock Awards$170.2M
Bonus$81.1M
Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.
← Back to database · Mayukh Sukhatme's full profile · Michael A. Marks's full profile
ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy